Catalyst Wire Dossier Catalyst Wire Dossier

NIO752

· Novartis Pharmaceuticals
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for NIO752, covering 2025-08-28 to 2026-03-27. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy of NIO752 in Participants With Progressive Supranuclear Palsy [Phase 3]

See pricing